share_log

Adaptimmune Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-EcoR1 Capital, LLC(10.7%),Oleg Nodelman(10.7%), etc.

Adaptimmune Therapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)

Adaptimmune Therapeutics | SC 13G/A:超過5%持股股東披露文件(修正)
SEC announcement ·  03/26 12:04
声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息